Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2024

Turbo Energy (NASDAQ: TURB) Drives AI Innovation within Residential Energy Storage Solutions

The growing demands of artificial intelligence (“AI”) are set to drive a sharp increase in data center storage capacity, with the latter expected to grow from 10.1 zettabytes (“ZB”) in 2023 to 21.0 ZB in 2027, a five-year compound annual … Continue reading

Posted in Turbo Energy S.A. TURB | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for its HYPER-H23-1 phase 1b hypertension clinical trial. The … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Financial Report, Company Update on ‘Strongest Quarter to Date’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting financial results for the three months ended Dec. 31, 2023; the company is also reporting a business update. Highlights of the report included the company regaining compliance with … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR) Names MarineMax Executive to Board

Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, announced that Anthony E. Cassella Jr., executive vice president finance and chief accounting officer at MarineMax Inc. (NYSE: HZO) has been appointed to … Continue reading

Posted in Vision Marine Technologies Inc. VMAR | Leave a comment

MissionIRNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’

Renovaro (NASDAQ: RENB) today announced the completion of its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of … Continue reading

Posted in Renovaro BioSciences Inc. RENB | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as head of business development and sales. … Continue reading

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks – ROTH MKM Provides D-Wave Quantum Inc. (NYSE: QBTS) Analyst Day Takeaways, Reiterates Buy Rating

ROTH MKM attended D-Wave Quantum Inc.’s (“D-Wave” or “QBTS”) annual analyst day recently held at the company’s research & development headquarters. Suji Desilva, CFA, Managing Director and Senior Research Analyst at ROTH MKM, published an update as part of the … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – WestPark Capital Reiterates Buy Rating on D-Wave Quantum Inc. (NYSE: QBTS), Recaps Analyst Day Visit

WestPark Capital recently published its recap of the recent analyst day event hosted by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software and services. Highlights of the visit included discussions … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q2 2024 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is releasing its financial results for Q2 2024, the period ended Dec. 31, 2023. Highlights of the report include a 512% increase in year-to-date revenue, which reached $1,540,000 compared to $301,000 … Continue reading

Posted in Astrotech Corp. ASTC | Leave a comment

Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in Neurodegenerative Disease with CNM-Au8(R)

Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is working on a potentially groundbreaking … Continue reading

Posted in Clene Inc. CLNN | Leave a comment